A secreted form of the Asialoglycoprotein receptor, sH2a, as a novel potential noninvasive marker for liver fibrosis

PLoS ONE

Volumn 6, Issue 11, 2011, Pages

  Veselkin, Elena ^a   Kondratyev, Maria ^a   Lurie, Yoav ^b   Ron, Efrat ^a   Santo, Moshe ^b   Reif, Shimon ^b   Elashvili, Irma ^b   Bar, Lana ^b   Lederkremer, Gerardo Z ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; ASIALOGLYCOPROTEIN RECEPTOR; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CHOLESTEROL; GAMMA GLUTAMYLTRANSFERASE; MONOCLONAL ANTIBODY; BIOLOGICAL MARKER;

ADULT; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE MARKER; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; LIVER FIBROSIS; LIVER FUNCTION TEST; MALE; NON INVASIVE MEASUREMENT; PREDICTION; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; BLOOD; CONFIDENCE INTERVAL; HEPATITIS C; IN VITRO STUDY; LIVER CIRRHOSIS; METABOLISM; MIDDLE AGED; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

HEPATITIS C VIRUS;

ADULT; ALANINE TRANSAMINASE; ASIALOGLYCOPROTEIN RECEPTOR; ASPARTATE AMINOTRANSFERASES; BILIRUBIN; BIOLOGICAL MARKERS; CONFIDENCE INTERVALS; FEMALE; HEPATITIS C; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; YOUNG ADULT;

EID: 80855128849     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0027210     Document Type: Article

References (27)

1. Tolchinsky S, Yuk MH, Ayalon M, Lodish HF, Lederkremer GZ, (1996) Membrane-bound versus secreted forms of human asialoglycoprotein receptor subunits- Role of a juxtamembrane pentapeptide. J Biol Chem 271: 14496-14503.
2. Lederkremer GZ, Lodish HF, (1991) An alternatively spliced miniexon alters the subcellular fate of the human asialoglycoprotein receptor H2 subunit. Endoplasmic reticulum retention and degradation or cell surface expression. J Biol Chem 266: 1237-1244.
3. Benyair R, Kondratyev M, Veselkin E, Tolchinsky S, Shenkman M, et al. (2011) Constant serum levels of secreted asialoglycoprotein receptor sH2a and decrease with cirrhosis. World J Gastroenterol in press.
4. Kudo M, Vera DR, Trudeau WL, Stadalnik RC, (1991) Validation of in vivo receptor measurements via in vitro radioassay: technetium-99m-galactosyl-neoglycoalbumin as prototype model. J Nucl Med 32: 1177-1182.
5. Drickamer K, (1991) Clearing up glycoprotein hormones. Cell 67: 1029-1032.
6. Stockert RJ, (1995) The asialoglycoprotein receptor: relationships between structure, function, and expression. Physiol Rev 75: 591-609.
7. Trere D, Fiume L, De Giorgi LB, Di Stefano G, Migaldi M, et al. (1999) The asialoglycoprotein receptor in human hepatocellular carcinomas: its expression on proliferating cells. Br J Cancer 81: 404-408.
8. Ishii H, (1998) Mechanisms of ethanol-induced impairment in asialoglycoprotein receptor expression and function. J Gastroenterol 33: 920-921.
9. Burgess JB, Baenziger JU, Brown WR, (1992) Abnormal surface distribution of the human asialoglycoprotein receptor in cirrhosis. Hepatology 15: 702-706.
10. Pimstone NR, Stadalnik RC, Vera DR, Hutak DP, Trudeau WL, (1994) Evaluation of hepatocellular function by way of receptor-mediated uptake of a technetium-99m-labeled asialoglycoprotein analog. Hepatology 20: 917-923.
11. Thuluvath PJ, Krok KL, (2006) Noninvasive markers of fibrosis for longitudinal assessment of fibrosis in chronic liver disease: are they ready for prime time? Am J Gastroenterol 101: 1497-1499.
12. Jarcuska P, Janicko M, Veseliny E, Skladany L, (2010) Circulating markers of liver fibrosis progression. Clin Chim Acta 411: 1009-1017.
13. Rossi E, Adams LA, Bulsara M, Jeffrey GP, (2007) Assessing liver fibrosis with serum marker models. Clin Biochem Rev 28: 3-10.
14. Bissell DM, (2004) Assessing fibrosis without a liver biopsy: Are we there yet? Gastroenterology 127: 1847-1849.
15. Bedossa P, Poynard T, (1996) An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 24: 289-293.
16. Higuchi H, Gores GJ, (2003) Mechanisms of liver injury: an overview. Curr Mol Med 3: 483-490.
17. Bataller R, Brenner DA, (2005) Liver fibrosis. J Clin Invest 115: 209-218.
18. Gressner OA, Weiskirchen R, Gressner AM, (2007) Biomarkers of liver fibrosis: clinical translation of molecular pathogenesis or based on liver-dependent malfunction tests. Clin Chim Acta 381: 107-113.
19. McHutchison JG, Blatt LM, de Medina M, Craig JR, Conrad A, et al. (2000) Measurement of serum hyaluronic acid in patients with chronic hepatitis C and its relationship to liver histology. Consensus Interferon Study Group. J Gastroenterol Hepatol 15: 945-951.
20. Kelleher TB, Mehta SH, Bhaskar R, Sulkowski M, Astemborski J, et al. (2005) Prediction of hepatic fibrosis in HIV/HCV co-infected patients using serum fibrosis markers: the SHASTA index. J Hepatol 43: 78-84.
21. Poynard T, Morra R, Halfon P, Castera L, Ratziu V, et al. (2007) Meta-analyses of FibroTest diagnostic value in chronic liver disease. BMC Gastroenterol 7: 40.
22. Shaheen AA, Myers RP, (2007) Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis C-related fibrosis: a systematic review. Hepatology 46: 912-921.
23. Fontana RJ, Goodman ZD, Dienstag JL, Bonkovsky HL, Naishadham D, et al. (2008) Relationship of serum fibrosis markers with liver fibrosis stage and collagen content in patients with advanced chronic hepatitis C. Hepatology 47: 789-798.
24. Degos F, Perez P, Roche B, Mahmoudi A, Asselineau J, et al. (2010) Diagnostic accuracy of FibroScan and comparison to liver fibrosis biomarkers in chronic viral hepatitis: a multicenter prospective study (the FIBROSTIC study). J Hepatol 53: 1013-1021.
25. Castera L, (2009) Transient elastography and other noninvasive tests to assess hepatic fibrosis in patients with viral hepatitis. J Viral Hepat 16: 300-314.
26. Takemoto R, Nakamuta M, Aoyagi Y, Fujino T, Yasutake K, et al. (2009) Validity of FibroScan values for predicting hepatic fibrosis stage in patients with chronic HCV infection. J Dig Dis 10: 145-148.
27. Kokudo N, Vera DR, Tada K, Koizumi M, Seki M, et al. (2002) Predictors of successful hepatic resection: prognostic usefulness of hepatic asialoglycoprotein receptor analysis. World J Surg 26: 1342-1347.